Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Ingwersen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Chromatography|November 15, 1991
Column liquid chromatographic assay of the dopamine reuptake inhibitor vanoxerine (GBR 12909) in human serumS H Ingwersen
Biomedical Chromatography : BMC|May 1, 1993
Combined reversed phase and anion exchange solid phase extraction for the assay of the neuroprotectant NBQX in human plasma and urineS H Ingwersen
Annals of Clinical Biochemistry|May 1, 1985
Immunoturbidimetry of serum C-reactive protein in low concentration of polyethylene glycolI Byrjalsen, S H Ingwersen
British Journal of Clinical Pharmacology|March 1, 1993
Food intake increases the relative oral bioavailability of vanoxerineS H Ingwersen, T G Mant, J J Larsen
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2015
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug DevelopmentR V Overgaard, S H Ingwersen, C W Tornøe
European Journal of Clinical Pharmacology|January 1, 1992
Human pharmacokinetics of an analogue of atrial natriuretic factorS H Ingwersen, H Eiskjaer, M Schmiegelow, et al.
Journal of Pharmaceutical Sciences|November 1, 1993
Nonlinear multiple-dose pharmacokinetics of the dopamine reuptake inhibitor vanoxerineS H Ingwersen, S Snel, T G Mant, et al.
Biopharmaceutics & Drug Disposition|April 4, 2003
Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulatorO Østerberg, B Kiehr, L Erichsen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2000
Population pharmacokinetics of tiagabine in epileptic patients on monotherapyS H Ingwersen, P C Pedersen, L Groes, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin ModelR M Røge, S Klim, S H Ingwersen, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Chromatography|November 15, 1991
Column liquid chromatographic assay of the dopamine reuptake inhibitor vanoxerine (GBR 12909) in human serumS H Ingwersen
Biomedical Chromatography : BMC|May 1, 1993
Combined reversed phase and anion exchange solid phase extraction for the assay of the neuroprotectant NBQX in human plasma and urineS H Ingwersen
Annals of Clinical Biochemistry|May 1, 1985
Immunoturbidimetry of serum C-reactive protein in low concentration of polyethylene glycolI Byrjalsen, S H Ingwersen
British Journal of Clinical Pharmacology|March 1, 1993
Food intake increases the relative oral bioavailability of vanoxerineS H Ingwersen, T G Mant, J J Larsen
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2015
Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug DevelopmentR V Overgaard, S H Ingwersen, C W Tornøe
European Journal of Clinical Pharmacology|January 1, 1992
Human pharmacokinetics of an analogue of atrial natriuretic factorS H Ingwersen, H Eiskjaer, M Schmiegelow, et al.
Journal of Pharmaceutical Sciences|November 1, 1993
Nonlinear multiple-dose pharmacokinetics of the dopamine reuptake inhibitor vanoxerineS H Ingwersen, S Snel, T G Mant, et al.
Biopharmaceutics & Drug Disposition|April 4, 2003
Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulatorO Østerberg, B Kiehr, L Erichsen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2000
Population pharmacokinetics of tiagabine in epileptic patients on monotherapyS H Ingwersen, P C Pedersen, L Groes, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin ModelR M Røge, S Klim, S H Ingwersen, et al.
Pageof 2